Loading...
XASXADR
Market cap5mUSD
Dec 20, Last price  
0.01AUD
1D
8.33%
1Q
0.00%
Jan 2017
-99.64%
IPO
-99.87%
Name

Adherium Ltd

Chart & Performance

D1W1MN
XASX:ADR chart
P/E
—
P/S
10.82
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
101.89%
Rev. gr., 5y
-21.26%
Revenues
841k
-73.68%
559,525480,9332,907,0002,100,8002,347,0005,867,0002,779,0002,218,000401,000529,0003,195,000840,982
Net income
-10m
L+3.71%
-138,506-2,206,911-1,255,000-6,308,000-12,810,000-9,338,000-11,794,000-11,397,000-15,036,000-10,044,000-9,858,000-10,224,173
CFO
-11m
L+14.39%
0-2,161,61123,000-7,913,000-11,581,000-9,824,000-11,807,000-7,317,000-11,273,000-9,610,000-9,278,000-10,613,012
Earnings
Feb 26, 2025

Profile

Adherium Limited develops, manufactures, and supplies digital health technologies that address sub-optimal medication use in chronic diseases in New Zealand, Australia, Europe, North America, and Asia. The company offers Hailie, an asthma and chronic obstructive pulmonary disease medication adherence solution for patients with chronic respiratory diseases. It also provides Bluetooth enabled Hailie sensors, which wrap around a patient's inhalers and offers real-time feedback to patients; Hailie app; and Hailie portal. The company was incorporated in 2001 and is based in Auckland, New Zealand.
URL
https://www.adherium.com/
IPO date
Aug 26, 2015
Employees
Domiciled in
NZ
Incorporated in
AU

Valuation

Title
AUD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑062023‑062022‑062021‑062020‑062019‑062018‑062017‑062016‑062015‑03
Income
Revenues
841
-73.68%
3,195
503.97%
529
31.92%
Cost of revenue
12,826
15,088
13,403
Unusual Expense (Income)
NOPBT
(11,985)
(11,893)
(12,874)
NOPBT Margin
Operating Taxes
(1,450)
(1,838)
(2,807)
Tax Rate
NOPAT
(10,535)
(10,055)
(10,067)
Net income
(10,224)
3.71%
(9,858)
-1.85%
(10,044)
-33.20%
Dividends
Dividend yield
Proceeds from repurchase of equity
7,729
12,327
BB yield
-115.69%
-120.77%
Debt
Debt current
47
44
42
Long-term debt
93
44
86
Deferred revenue
Other long-term liabilities
11
Net debt
(6,058)
(8,989)
(5,155)
Cash flow
Cash from operating activities
(10,613)
(9,278)
(9,610)
CAPEX
(41)
(279)
Cash from investing activities
(37)
(41)
(279)
Cash from financing activities
7,729
13,071
FCF
(10,741)
(9,898)
(10,278)
Balance
Cash
6,198
9,077
5,283
Long term investments
Excess cash
6,155
8,917
5,257
Stockholders' equity
241,037
9,214
5,537
Invested Capital
429
341
365
ROIC
ROCE
EV
Common stock shares outstanding
371,139
272,205
144,928
Price
0.02
-52.00%
0.04
-64.29%
0.11
-58.82%
Market cap
6,681
-34.55%
10,207
-32.92%
15,217
-0.65%
EV
622
1,218
10,062
EBITDA
(11,985)
(11,702)
(12,688)
EV/EBITDA
Interest
2
Interest/NOPBT